Biocon advanced 3.17% to Rs 328.75 after Biocon Biologics (BBL) secures multiple market access agreements in the United States for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab), ...

Cigna raised its full-year profit forecast after outperforming expectations in Q1, largely thanks to its pharmacy benefit ...

The health sector faces a tumultuous period as the U.S. government proposes budget cuts impacting key research institutions, ...

Hartford- based Aetna plans to pull out of Affordable Care Act health-insurance exchanges nationwide next year, parent company CVS Health announced on Thursday. "We're disappointed by the continued ...

Cigna Group on Friday reported a $1.3 billion profit for the first quarter of 2025, a sharp turnaround from a year-earlier ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all ...

Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid ...

The results make UnitedHealth Group’s earnings blowup last month look less and less like a sector-wide problem.

Cigna on Friday raised its full-year earnings forecast and beat estimates for quarterly profit, helped by strong performance ...

Cigna swung to a first quarter profit of $1.3 billion as the health insurer gains control of rising medical costs and its ...